(Q37729195)

22 August 2017

1 reference

title

Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. (English)

1 reference

22 August 2017

1 reference

Jolie Ringash

2

0 references

author name string

Heather-Jane Au

1

1 reference

22 August 2017

Michael Brundage

3

1 reference

22 August 2017

Michael Palmer

4

1 reference

22 August 2017

Harriet Richardson

5

1 reference

22 August 2017

Ralph M Meyer

6

1 reference

22 August 2017

NCIC CTG Quality of Life Committee

7

1 reference

22 August 2017

publication date

1 April 2010

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

119-128

1 reference

Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.

22 August 2017

cites work

1 reference

International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience

21 January 2018

1 reference

Outcomes research in cancer symptom management trials: the Radiation Therapy Oncology Group (RTOG) conceptual model.

21 January 2018

1 reference

Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program

21 January 2018

1 reference

The clinical significance of quality of life assessments in oncology: a summary for clinicians

21 January 2018

1 reference

Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

Do general dimensions of quality of life add clinical value to symptom data?

21 January 2018

1 reference

Measuring outcomes in oncology treatment: the importance of patient-centered outcomes

21 January 2018

1 reference

Patient-reported outcomes to evaluate surgery

21 January 2018

1 reference

Patient-reported outcomes in cancer: a review of recent research and policy initiatives

21 January 2018

1 reference

Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making

21 January 2018

1 reference

Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?

21 January 2018

1 reference

The McGill Pain Questionnaire: Major properties and scoring methods

21 January 2018

1 reference

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

Cetuximab for the treatment of colorectal cancer.

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

21 January 2018

1 reference

Erlotinib in previously treated non-small-cell lung cancer

21 January 2018

1 reference

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

21 January 2018

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

21 January 2018

1 reference

21 January 2018

1 reference

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

21 January 2018

1 reference

Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.

21 January 2018

1 reference

Development of a measure of physical function for patients with bone and soft tissue sarcoma.

21 January 2018

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

The paradox of response and survival in cancer therapeutics

21 January 2018

1 reference

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.

21 January 2018

1 reference

Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial

21 January 2018

1 reference

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

21 January 2018

1 reference

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women

21 January 2018

1 reference

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

21 January 2018

1 reference

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

21 January 2018

1 reference

The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.

21 January 2018

1 reference

Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group.

21 January 2018

1 reference

The prognostic significance of patient-reported outcomes in cancer clinical trials

21 January 2018

1 reference

Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.

21 January 2018

1 reference

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

21 January 2018

1 reference

Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

21 January 2018

1 reference

21 January 2018

1 reference

Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B.

21 January 2018

1 reference

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapy.

21 January 2018

1 reference

Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial.

21 January 2018

1 reference

21 January 2018

1 reference

Economic evaluations of medical care interventions for cancer patients: how, why, and what does it mean?

21 January 2018

1 reference

Interpreting the significance of changes in health-related quality-of-life scores.

21 January 2018

1 reference

Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience

21 January 2018

1 reference

Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation.

21 January 2018

1 reference

Applying item response theory and computer adaptive testing: the challenges for health outcomes assessment

21 January 2018

1 reference

Translating the science of patient-reported outcomes assessment into clinical practice

21 January 2018

1 reference

Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.

21 January 2018

1 reference

The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years

21 January 2018

1 reference

Practical and philosophical issues surrounding a national item bank: if we build it will they come?

21 January 2018

1 reference

Importance of patient-centered care in enhancing patient well-being: a cancer survivor's perspective.

21 January 2018

1 reference

The applications of PROs in clinical practice: what are they, do they work, and why?

21 January 2018

1 reference

Using patient-reported outcomes in clinical practice: challenges and opportunities

21 January 2018

1 reference

Future directions in QOL research

21 January 2018

1 reference

Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.10.15

1 reference

release_drtnln27yfb3bjufr57ngywx74

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/drtnln27yfb3bjufr57ngywx74

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference